Skip to main content
    M

    Mink Therapeutics Inc (INKT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.29
    -0.07 (-0.70%)

    Market Cap: $47.95M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Mink Therapeutics Inc (INKT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Mink Therapeutics (INKT) has a market cap of $47.95M and an enterprise value of $40.48M. It kept -5512.48% of revenue as net income over the last 12 months. Revenue fell 99.99% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 15.58% below the market cap, as cash exceeds debt.

    Market Cap$47.95M
    Enterprise Value$40.48M
    Latest price (Nov 17, 2026)$9.29

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.58% in the quarter ended Sep 30, 2026 and grew 13.61% a year over 2 years.

    Shares Outstanding5.10M
    Shares Change (YoY)+14.84%
    Shares Change (QoQ)+1.58%
    Share Count Growth (2Y CAGR)+13.61%

    Price Statistics

    The stock is down 27.18% over 52 weeks and trades 15.62% below its 50-day average.

    Beta (1Y)0.61
    52-Week Change-27.18%
    1-Month Change-2.88%
    3-Month Change-16.58%
    6-Month Change-10.29%
    5-Year Change-94.11%
    Total Return (1Y)-27.18%
    Total Return (3Y CAGR)-3.40%
    Total Return (5Y CAGR)-43.43%
    Return vs SPY (1Y)-29.46%
    Max Drawdown (1Y)-36.64%
    Max Drawdown (3Y)-86.66%
    Sharpe Ratio (1Y)-0.28
    Correlation with SPY (1Y)0.12
    50-Day Average$11.01
    200-Day Average$11.16
    52-Week Range$8.48 to $16.93
    RSI (14 Days)35.8
    Average Volume (20 Days)13.20K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.97x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio0.97x
    Quick Ratio0.97x
    Debt / Equity0.00x
    Interest Coverage33.69x

    Returns and Efficiency

    Return on Assets (ROA)-133.75%
    ROIC (5Y Average)70.38%
    Asset Turnover0.02x

    Scores

    INKT has an Altman Z-Score of -31.44, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-31.44
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $200.00K over the last 12 months.

    Revenue$200.00K
    Revenue Growth (YoY)-99.99%
    Gross Profit$161.44K
    Operating Income-$11.44M
    Pretax Income-$11.02M
    Net Income-$11.02M
    Reported EPS (TTM)-$2.25

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$7.47M
    Total Debt$0
    Net Cash$7.47M
    Net Cash Per Share$1.46
    Working Capital-$271.34K
    Shareholder Equity-$16.25M
    Total Assets$8.24M
    Total Liabilities$24.49M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$7.16M
    FCF Per Share-$1.42
    Depreciation and Amortization$146.76K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -5720.70%.

    Gross Margin80.72%
    Operating Margin-5720.70%
    Pretax Margin-5512.48%
    Net Margin-5512.48%

    Dividends and Yields

    INKT does not pay a dividend.

    Buyback Yield-11.14%
    Shareholder Yield-11.14%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jan 28, 2025.

    Last Split DateJan 28, 2025
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 3 similar companies, INKT has the 2nd highest P/S.

    P/S Ratio236.9x vs 83.5x median
    Revenue Growth (Trailing 4 Quarters, YoY)-99.99% vs -100.00% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About INKT

    What is INKT's market cap?

    Mink Therapeutics has a market cap of $47.95M. Its enterprise value, which adds debt and subtracts cash, is $40.48M.

    How many shares of INKT are outstanding?

    Mink Therapeutics has 5.10M shares outstanding. The count is up 14.84% from a year earlier.

    Does INKT pay a dividend?

    No. Mink Therapeutics does not pay a dividend.

    How much debt does INKT have?

    Mink Therapeutics has $0 of total debt and $7.47M of cash and equivalents, a net cash position of $7.47M.